Evidence map›Paper›PMID 35008799›Full record

ArticleInternational journal of molecular sciences2021

High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling.

Irene Tveiterås Øvestad, Birgit Engesæter, Mari Kyllesø Halle, Saleha Akbari, Beatrix Bicskei, Morten Lapin, Marie Austdal, Emiel A M Janssen, Camilla Krakstad, Melinda Lillesand and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Irene Tveiterås ØvestadDepartment of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.
Birgit EngesæterSection for Cervical Cancer Screening, Cancer Registry of Norway, 0304 Oslo, Norway.
Mari Kyllesø HalleDepartment of Obstetrics and Gynaecology, Haukeland University Hospital, 5053 Bergen, Norway.ORCID 0000-0002-2660-8271
Saleha AkbariDepartment of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.
Beatrix BicskeiDepartment of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.
Morten LapinDepartment of Haematology and Oncology, Stavanger University Hospital, 4011 Stavanger, Norway.
Marie AustdalSection of Biostatistics, Department of Research, Stavanger University Hospital, 4011 Stavanger, Norway.
Emiel A M JanssenDepartment of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.ORCID 0000-0002-7760-5396
Camilla KrakstadDepartment of Obstetrics and Gynaecology, Haukeland University Hospital, 5053 Bergen, Norway.ORCID 0000-0002-0174-8139
Melinda LillesandDepartment of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.
Marit NordhusDepartment of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.
Ane Cecilie MunkDepartment of Gynaecology, Sørlandet Hospital, 4604 Kristiansand, Norway.
Einar G GudlaugssonDepartment of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.
Stavanger University Hospital · NOHaukeland University Hospital · NOCancer Registry of Norway · NOSørlandet Sykehus · NO

Funding

Folke Hermansen Fond year (2014-20219
6 · The paper itself

Abstract

Implementation of high-risk human papilloma virus (HPV) screening and the increasing proportion of HPV vaccinated women in the screening program will reduce the percentage of HPV positive women with oncogenic potential. In search of more specific markers to identify women with high risk of cancer development, we used RNA sequencing to compare the transcriptomic immune-profile of 13 lesions with cervical intraepithelial neoplasia grade 3 (CIN3) or adenocarcinoma in situ (AIS) and 14 normal biopsies from women with detected HPV infections. In CIN3/AIS lesions as compared to normal tissue, 27 differential expressed genes were identified. Transcriptomic analysis revealed significantly higher expression of a number of genes related to proliferation, (

Indexed as

Signal TransductionAdultBiopsyCell ProliferationCohort StudiesFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGene OntologyHumansMiddle AgedNeoplasm GradingNeoplasm ProteinsPapillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsNeoplasm Proteinscervical cancer screeningCIN progressiondifferential gene expressiontranscriptomic analysis

Identifiers

PMID35008799
PMCPMC8745058
OpenAlexW4200510853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.